English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/125075
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Microparticles in multiple sclerosis and clinically isolated syndrome: Effect on endothelial barrier function

AuthorsMarcos Ramiro, Beatriz ; Millán, Jaime ; Cernuda-Morollón, Eva
KeywordsMultiple sclerosis
Clinically isolated syndrome
Microparticles
Endothelial barrier function
Thrombin
Issue Date22-Sep-2014
PublisherBioMed Central
CitationBMC Neuroscience 15: 110 (2014)
Abstract[Background] Cell-derived microparticles are secreted in response to cell damage or dysfunction. Endothelial and platelet dysfunction are thought to contribute to the development of multiple sclerosis (MS). Our aim here is, first, to compare the presence of microparticles of endothelial and platelet origin in plasma from patients with different clinical forms of MS and with clinically isolated syndrome. Second, to investigate the effect of microparticles on endothelial barrier function.
[Results] Platelet-poor plasma from 95 patients (12 with clinically isolated syndrome, 51 relapsing-remitting, 23 secondary progressive, 9 primary progressive) and 49 healthy controls were analyzed for the presence of platelet-derived and endothelium-derived microparticles by flow cytometry. The plasma concentration of platelet-derived and endothelium-derived microparticles increased in all clinical forms of MS and in clinically isolated syndrome versus controls. The response of endothelial barriers to purified microparticles was measured by electric cell-substrate impedance sensing. Microparticles from relapsing-remitting MS patients induced, at equivalent concentrations, a stronger disruption of endothelial barriers than those from healthy donors or from patients with clinically isolated syndrome. MS microparticles acted synergistically with the inflammatory mediator thrombin to disrupt the endothelial barrier function.
[Conclusions] Plasma microparticles should be considered not only as markers of early stages of MS, but also as pathological factors with the potential to increase endothelial permeability and leukocyte infiltration.
Publisher version (URL)http://dx.doi.org/10.1186/1471-2202-15-110
URIhttp://hdl.handle.net/10261/125075
DOI10.1186/1471-2202-15-110
ISSN1471-2202
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
Cernuda-Morollón_MicroparticlesinMultipleSclerosis.pdf2,91 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.